FEIM -- Frequency Electronics
Identity
| Field | Detail |
|---|---|
| Full Name | Frequency Electronics, Inc. |
| Ticker | FEIM (NASDAQ) |
| HQ | 55 Charles Lindbergh Blvd, Mitchel Field, NY 11553 |
| Founded | August 25, 1961 by Martin B. Bloch |
| IPO | 1966 |
| Fiscal Year End | April 30 |
| Employees | 226 |
| Market Cap | ~$397M (Mar 2026) |
| Enterprise Value | ~$405M |
| Shares Outstanding | 9.84M (basic); ~9.78-9.84M (diluted) |
| 52-Week Range | $14.41 -- $61.47 |
Leadership
| Role | Name |
|---|---|
| CEO / President / Director | Dr. Thomas McClelland (permanent CEO since Jan 17, 2023; 40-year FEI veteran, former Chief Scientist) |
| Executive Chairman / Chief Scientific Officer | Martin B. Bloch (founder; director since 1961; age ~93) |
| Chairman of the Board | Gen. Lance W. Lord (Ret.) |
| CFO / Secretary / Treasurer | Steven L. Bernstein |
| SVP, Business Development | Oleandro Mancini |
| President, FEI-Elcom Tech | James Jerome Davis |
Thesis
Precision timing and frequency specialist serving US government satellite and military C4ISR/EW applications. The only publicly traded pure-play in high-precision timing for space/defense. 63 years of flight heritage across 120+ space programs. Leveraging atomic clock expertise (Rubidium, Cesium, Mercury Ion) with growing quantum sensors TAM.
The bull case in one sentence: FEIM is an irreplaceable franchise riding proliferated satellites, Golden Dome missile defense, counter-UAS, and quantum sensing -- with a record $83M backlog heading to $100M+ and zero direct public-market competition.
The bear case in one sentence: At $40 and 6x EV/Revenue, the stock is priced for a future that hasn't arrived yet -- the DCF says $11-19/share, and the gap is entirely scarcity premium, M&A optionality, and narrative momentum.
Where I land: Fair value as a standalone business is $11-19 on a DCF basis. Fair value incorporating strategic/scarcity premium is $30-45. At $40, you're paying full price for the franchise and getting limited margin of safety. The 34% pullback from $61 helped, but this isn't cheap by any traditional metric. If you're buying here, you're betting on TURbO + quantum reaching commercial scale, backlog converting to $100M+ revenue within 3 years, and/or an acquirer paying 5-8x revenue.
Business
What They Do
Frequency Electronics designs, develops, manufactures, and sells precision time and frequency control products and components for microwave integrated circuit applications. Products are used in:
- Satellite payloads (master clocks for MILSTAR, AEHF, GPS III)
- Missiles (Patriot, THAAD)
- UAVs / drones
- Piloted aircraft (B-2 bomber)
- GPS systems and secure radios (Link 16)
- Electronic warfare suites
- Missile defense systems (Golden Dome initiative)
- SCADA systems
- Wireline and wireless communication networks
Business Segments
FEI-NY (73% of FY2024 sales): Precision timing/frequency for satellite payloads (commercial and US government). Non-space DoD includes airborne/ground-based guidance, navigation, communications, EW. Sub-divisions: FEI Government Systems, FEI Communications, FEI-Elcom (RF microwave to 60GHz). R&D at ~10% of sales.
FEI-Zyfer (27% of FY2024 sales, growing): GNSS/GPS-based precision timing for secure communications. Ruggedized atomic clocks with anti-jam/anti-spoof capability. 91% revenue from US government end-users. Applications: Radar, SIGINT/COMINT, command & control, satellite ground stations. Also developing Assured-PNT (GPS-denied navigation) systems.
Revenue by Customer Type
| Segment | FY2023 | FY2024 | FY2025 | Q3 FY2026 (3mo) |
|---|---|---|---|---|
| Satellite Payloads | $17.9M (44%) | $23.2M (42%) | $40.9M (59%) | $4.2M (25%) |
| Non-Space U.S. Gov't/DoD | $20.3M (50%) | $29.0M (52%) | $26.5M (38%) | $12.5M (74%) |
| Commercial/Industrial | $2.6M (6%) | $3.1M (6%) | $2.4M (3%) | $0.2M (1%) |
| Total | $40.8M | $55.3M | $69.8M | $16.9M |
US government end-use (direct + subcontracts): ~94% of revenue. This is essentially a domestic US defense/space supplier.
Key Products
- Crystal Oscillators -- precision quartz oscillators, acceleration-compensated OCXOs
- Atomic Clocks -- rubidium standards, cesium standards, hydrogen masers
- TURbO (Time Unit Rubidium Oscillator) -- miniaturized atomic clock for drone fleets and airborne radars; ~$20M annual market opportunity starting FY2027
- GPS Receivers -- secure positioning systems
- Frequency Synthesizers / Converters
- Assured-PNT Systems -- GPS-denied navigation solutions
- NV-Diamond Magnetometers -- quantum sensing for magnetic field navigation (emerging)
Competitive Moat
- Pure-play scarcity -- only publicly traded pure-play in high-precision timing for space/defense
- 63-year flight heritage -- products on 120+ space programs; Voyager-era pedigree
- ITAR compliance / Buy American -- US-only production creates regulatory moat
- Vertical integration -- designs and manufactures in-house
- Switching costs -- six-decade flight record and qualification data create extreme switching costs
- Radiation hardening -- leading US provider of rad-hard atomic clocks for space
- Institutional knowledge -- specialized physicists and engineers that competitors can't replicate
- GPS-denied warfare -- positioned at the center of the PNT Sovereignty trend
Key Customers
US DoD, NASA, Lockheed Martin (primary), L3Harris, Mercury Systems, Northrop Grumman, Raytheon, commercial satellite operators.
Competitors
- Microchip Technology (MCHP): Dominates terrestrial timing; pushing into defense
- Safran/Orolia: Pursuing "Time-as-a-Service" model
- SiTime: Silicon MEMS-based timing (lower precision but cheaper)
- In-house capabilities: Boeing, Northrop, Lockheed for certain applications
Key Development Programs
- Mercury Ion Atomic Clock (Hg+ Ion Clock): Production launch 2027. Making clock manufacturable from trapped-ion technology.
- TURbO: Miniaturized rubidium atomic clock for drone fleets/airborne radars. "Beginning to see significant revenue... going to grow dramatically over the next couple of quarters." ~$20M/year market by FY2027.
- Next-gen optical atomic clocks (development stage)
- Photonic microwave sources (development stage)
- NV-Diamond Magnetometers: New Boulder, CO engineering facility. Quantum sensors expected mission-ready by early 2027.
- Quantum sensors market: $750M-$1B TAM (McKinsey 2025), 10-15% growth.
Management
Key-Person Risk
Martin Bloch (founder, age ~93) still serves as Executive Chairman / Chief Scientific Officer. He has been with the company since founding in 1961. His institutional knowledge is irreplaceable.
Dr. Tom McClelland (CEO) is a 40-year veteran and former Chief Scientist. Mitigates some succession risk, but the company is small and depth is limited.
Insider Ownership & Activity
- Insider ownership: 6.25% of shares outstanding
- Net insider buying: 4 insider buys, 0 insider sells in the past year
- Russell Sarachek (Director): Purchased 4,529 shares across multiple transactions (most recent: 1,582 shares at ~$15.77 on Mar 19, 2025; total holdings 461,619 shares)
- Edenbrook Capital (Director/19% owner): Purchased 10,000 shares in March 2024
- No insider selling activity reported
Capital Allocation
Buyback: September 2025 board authorized $20M share repurchase program. FY2025: $380K repurchased. LTM: $1.68M repurchased.
Dividends: No regular quarterly dividend. Special dividends only -- $1.00/share in January 2023 (~$9.3M) and August 2024 (~$9.6M). Total of 25 dividend payments historically ($6.29 cumulative per share, split-adjusted).
Quality Metrics
| Metric | Value |
|---|---|
| ROIC | 10.0% |
| ROE | 12.9% (LTM); 44.5% (FY2025 peak, tax-benefit-inflated) |
| ROA | 4.6% |
| Debt/Equity | 0.13x |
| Altman Z-Score | 6.32 (well above safe zone) |
| Piotroski F-Score | 3 (weak) |
Institutional Ownership
| Rank | Institution | Shares | % Outstanding |
|---|---|---|---|
| 1 | Edenbrook Capital | 1,874K | 19.2% |
| 2 | Wax Asset Management | ~689K | ~7.0% |
| 3 | Dimensional Fund Advisors | ~492K | ~5.0% |
Total institutional ownership: ~50-58%. Float: 6.88M shares.
Analyst Coverage
Only 2 analysts -- very thin coverage.
| Analyst | Firm | Rating | Price Target |
|---|---|---|---|
| Daniel Hibshman | Craig-Hallum | Buy | $60 |
| -- | Freedom Capital Markets | Hold | $42 |
Short interest: 556,913 shares (6.6% of outstanding, 9.45% of float). Days to cover: 3.4.
Financials
Cycle Context
FEIM's revenue doesn't grow linearly -- it swings with defense procurement cycles and satellite program timing. The 10-year window captures one full cycle: a deep trough (FY2018-FY2020, revenue bottomed at $39M) and a strong recovery (FY2024-FY2025, revenue peaked at $70M).
What caused the trough (FY2018-FY2020): Commercial satellite spending collapsed as old GEO programs wound down. FEIM got caught in a multi-year gap before the proliferated LEO boom. Revenue fell 29% from FY2016 to FY2018. Simultaneously took an $11.2M tax valuation allowance charge and divested Gillam (Belgium).
What caused the peak (FY2024-FY2025): Three simultaneous tailwinds: (1) proliferated satellite constellations, (2) defense spending surge on precision timing (Golden Dome, counter-UAS, missile defense), (3) TURbO moving from development to initial production.
Where we are now: Late-cycle. FY2025 margins were peak levels already normalizing in FY2026. But backlog is at an all-time record ($83M) and the contract pipeline is stronger than ever ($45M in fresh satellite awards). This is unusual -- backlog is still expanding while margins compress. The explanation: new proliferated satellite contracts have lower initial margins (higher production rates, lower per-unit pricing) than legacy GEO business. FEIM is trading margin quality for revenue quantity.
10-Year Income Statement ($K)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | LTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55,416 | 50,351 | 39,407 | 49,509 | 41,510 | 54,254 | 48,296 | 40,777 | 55,274 | 69,811 | 67,815 |
| Rev growth | -- | -9.1% | -21.7% | +25.6% | -16.2% | +30.7% | -11.0% | -15.6% | +35.6% | +26.3% | -2.9% |
| Gross profit | 20,436 | 11,249 | 5,163 | 15,789 | 5,800 | 16,921 | 8,599 | 7,849 | 18,583 | 30,097 | 25,737 |
| Gross margin | 36.9% | 22.3% | 13.1% | 31.9% | 14.0% | 31.2% | 17.8% | 19.2% | 33.6% | 43.1% | 37.9% |
| SG&A | 13,205 | 11,898 | 10,608 | 12,100 | 11,600 | 13,189 | 11,662 | 9,372 | 10,184 | 12,289 | -- |
| R&D | 5,929 | 6,876 | 6,950 | 6,506 | 5,100 | 4,690 | 4,975 | 3,149 | 3,380 | 6,076 | -- |
| SBC (memo) | 450 | 457 | 470 | 500 | 350 | 270 | 250 | 200 | 820 | 1,160 | -- |
| Op income | 1,302 | (7,525) | (12,395) | (2,817) | (10,900) | (958) | (8,038) | (4,672) | 5,019 | 11,732 | 6,627 |
| Op margin | 2.3% | -14.9% | -31.4% | -5.7% | -26.3% | -1.8% | -16.6% | -11.5% | 9.1% | 16.8% | 9.8% |
| Net income | 1,005 | (4,821) | (23,777) | (2,529) | (10,000) | 680 | (8,663) | (5,501) | 5,594 | 23,802 | 7,180 |
| EPS (diluted) | $0.11 | ($0.55) | ($2.69) | ($0.28) | ($1.10) | $0.07 | ($0.93) | ($0.59) | $0.59 | $2.48 | $0.73 |
FY2025 net income note: The $23.8M ($2.48 EPS) included ~$11.7M one-time DTA valuation allowance reversal. Normalized net income was ~$9.6M (~$1.00 EPS).
FY2018 tax charge: The $11.2M tax provision was non-cash -- full valuation allowance against US net deferred tax assets under TCJA.
Cycle Margin Analysis
| Metric | 10-Yr Low | Year | 10-Yr High | Year | LTM | 10-Yr Avg |
|---|---|---|---|---|---|---|
| Gross margin | 13.1% | FY2018 | 43.1% | FY2025 | 37.9% | 24.5% |
| Op margin | -31.4% | FY2018 | 16.8% | FY2025 | 9.8% | -6.9% |
| FCF margin | -7.3% | FY2019 | 20.1% | FY2021 | -5.6% | 3.1% |
Quarterly Financials -- Last 8 Quarters ($K)
| Quarter | End Date | Revenue | Gross Profit | GM % | EBIT | EBIT % | Net Income | EPS |
|---|---|---|---|---|---|---|---|---|
| Q4 FY2024 | Apr 30, 2024 | 15,576 | 6,281 | 40.3% | 2,494 | 16.0% | 2,625 | $0.28 |
| Q1 FY2025 | Jul 31, 2024 | 15,078 | 6,699 | 44.4% | 2,367 | 15.7% | 2,430 | $0.25 |
| Q2 FY2025 | Oct 31, 2024 | 15,820 | 7,619 | 48.2% | 2,618 | 16.6% | 2,654 | $0.28 |
| Q3 FY2025 | Jan 31, 2025 | 18,927 | 8,285 | 43.8% | 3,469 | 18.3% | 15,405 | $1.60 |
| Q4 FY2025 | Apr 30, 2025 | 19,986 | 7,493 | 37.5% | 3,278 | 16.4% | 3,312 | $0.34 |
| Q1 FY2026 | Jul 31, 2025 | 13,812 | 5,082 | 36.8% | 365 | 2.6% | 634 | $0.07 |
| Q2 FY2026 | Oct 31, 2025 | 17,127 | 6,536 | 38.2% | 1,714 | 10.0% | 1,801 | $0.18 |
| Q3 FY2026 | Jan 31, 2026 | 16,890 | 6,626 | 39.2% | 1,270 | 7.5% | 1,567 | $0.16 |
Q3 FY2025 net income of $15.4M includes the $11.7M DTA reversal. Normalized: ~$3.5-3.7M. Q4 FY2025 revenue of $20.0M was the highest quarterly revenue in 25 years per management. Q1 FY2026 revenue drop was contract milestone timing, not demand deterioration.
FY2026 9-month totals: Revenue $47,829K vs $49,825K prior year. Operating income $3,349K vs $8,453K. Margin compression reflects a shift toward earlier-stage, lower-margin work.
Incremental Margin Analysis (FY2026 vs FY2025)
The recent incrementals are ugly -- and that's the most important thing to understand. FY2025 was peak profitability and FY2026 is a transition year:
- Revenue timing: Q1 FY2026 dropped to $13.8M due to contract milestone timing. Normal lumpiness.
- Margin compression is real: Gross margins dropped from 44-48% in H1 FY2025 to 37-39% in FY2026. Management explicitly said proliferated satellite business will have "somewhat lower gross margins."
- SG&A creep: SG&A hit 21% of revenue in Q3 FY2026 (from 18% in FY2025), partly from the new Boulder, CO quantum sensing facility (~$500K/quarter added cost).
Bottom line for projections: Do NOT extrapolate FY2025's 43% gross margin or 17% operating margin as sustainable. The 10-year average gross margin is 24.5%. A realistic steady-state is 34-38% gross, 10-15% operating at $100M+ revenue.
Cash Flow ($K)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | LTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | 2,800 | 3,500 | 4,533 | (97) | (1,400) | 12,160 | 4,040 | 1,180 | 8,710 | (1,430) | (900) |
| Capex | (2,000) | (1,500) | (1,418) | (2,767) | (1,500) | (1,240) | (1,860) | (920) | (1,490) | (1,810) | (2,900) |
| Free cash flow | 800 | 2,000 | 3,115 | (2,864) | (2,900) | 10,920 | 2,180 | 260 | 7,220 | (3,240) | (3,800) |
| FCF margin | 1.4% | 4.0% | 7.9% | -5.8% | -7.0% | 20.1% | 4.5% | 0.6% | 13.1% | -4.6% | -5.6% |
| D&A | 3,600 | 3,400 | 2,484 | 2,802 | 3,000 | 3,300 | 3,030 | 2,430 | 2,120 | 2,060 | -- |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (9,350) | 0 | (9,570) | -- |
FY2025 FCF was -$3.2M despite $11.7M operating income because of working capital consumption -- contract assets (unbilled receivables) surged from $10.5M to $17.9M. This is timing, not structural. FY2024 FCF of $7.2M was the cleanest recent year.
Balance Sheet ($K)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | Q3 FY26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | 16,929 | 9,978 | 14,018 | 11,882 | 14,400 | 20,100 | 11,560 | 12,050 | 18,320 | 4,720 | 86 |
| Inventories | 36,280 | 29,051 | 26,186 | 23,356 | 23,000 | 19,660 | 19,910 | 20,530 | 23,430 | 23,490 | 25,800 |
| Contract Assets | -- | -- | 5,094 | 6,670 | n/a | n/a | n/a | n/a | 10,523 | 17,914 | -- |
| Total Assets | 122,177 | 113,319 | 83,584 | 86,771 | 91,300 | 98,530 | 84,760 | 74,500 | 83,250 | 93,740 | 94,200 |
| Long-term Debt | 6,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | 93,352 | 89,332 | 63,262 | 63,089 | 54,200 | 55,410 | 46,690 | 32,890 | 39,820 | 55,620 | 60,200 |
| Book Value/Share | $10.19 | $10.17 | $7.15 | $7.08 | $5.98 | $5.99 | $5.04 | $3.52 | $4.22 | $5.78 | $6.12 |
Cash dropped to $86K at Jan 31, 2026, but management stated $11M+ was collected after Feb 1, 2026 and described Q3-end as the "low point going forward." FEIM has been debt-free since FY2017. The "total debt" line in some sources (~$8M) includes operating lease liabilities, not bank borrowings. Working capital at Jan 31, 2026 was $32M.
Contract liabilities: Emerged as a major line item after ASC 606 adoption. Peaked at $21.6M (FY2024), now $13.6M (FY2025). These are customer advance payments on contracts.
Backlog (Funded)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $32M | $39M | $30M | $37M | $36M | $40M | $42M | $57M | $78M | $70M | $71M | $82M | $83M |
All-time record. ~69% expected to convert within 12 months. March 11, 2026: announced two satellite contracts totaling ~$45M that will begin entering funded backlog in Q4 FY2026. Management: backlog heading above $100M "relatively quickly." Also: "We anticipate multiple awards in the coming months, some of which are as large or larger than the largest contracts we have ever won."
Valuation Snapshot (Mar 2026)
| Metric | Value |
|---|---|
| Price | ~$40.38 |
| P/E (TTM) | 55.2x |
| Forward P/E | 34.2x (consensus FY2026E EPS ~$1.18-1.32) |
| EV/Revenue (TTM) | 6.0x |
| EV/EBITDA (TTM) | 47.0x |
| P/B | 6.60x |
| Beta (5Y) | 0.31 |
| Earnings Yield | 1.81% |
| 52-Week Performance | +155% |
DCF Valuation
Discount rate: WACC 10.5% (risk-free 4.37% + industry beta 0.85 x ERP 4.23% + micro-cap size premium 2.50%). Used industry beta over raw regression beta of 0.31-0.36 because FEIM's thin trading volume makes regression beta unreliably low. A sub-8% cost of equity would be absurd for a $400M micro-cap with 94% government customer concentration.
Base case revenue projections ($M):
| FY26E | Yr 1 (FY27) | Yr 2 (FY28) | Yr 3 (FY29) | Yr 4 (FY30) | Yr 5 (FY31) | |
|---|---|---|---|---|---|---|
| Satellite payloads | -- | $38.0 | $42.0 | $47.0 | $52.0 | $55.0 |
| Non-space DoD | -- | $36.0 | $40.0 | $44.0 | $48.0 | $52.0 |
| Commercial | -- | $3.0 | $3.1 | $3.2 | $3.2 | $3.4 |
| Total revenue | $66.0 | $77.0 | $85.1 | $94.2 | $103.2 | $110.4 |
| Revenue growth | -5.4% | +16.7% | +10.5% | +10.7% | +9.6% | +7.0% |
| Gross margin | 37.0% | 37.0% | 37.0% | 36.0% | 36.5% | 37.0% |
| Op margin | 9.6% | 10.5% | 10.5% | 10.0% | 11.5% | 12.0% |
Margins dip in FY2026-FY29 as proliferated satellite contracts come on at lower margins, then gradually recover toward 12% operating by FY2031 as volume-based leverage kicks in and TURbO (higher margin) reaches scale. I deliberately did NOT project a return to FY2025's 16.8% -- that was peak mix.
Unlevered FCF build ($M) -- base case:
| Yr 1 | Yr 2 | Yr 3 | Yr 4 | Yr 5 | |
|---|---|---|---|---|---|
| NOPAT | $6.3 | $7.0 | $7.3 | $9.3 | $10.3 |
| (+) D&A | $1.9 | $2.1 | $2.4 | $2.6 | $2.8 |
| (-) Capex | ($2.3) | ($2.6) | ($2.8) | ($3.1) | ($3.3) |
| (-) NWC change | ($2.2) | ($2.5) | ($2.5) | ($2.5) | ($1.5) |
| UFCF | $3.7 | $4.1 | $4.4 | $6.3 | $8.3 |
Terminal value: ROIC perpetuity ($111M) and exit multiple (14x EBITDA = $224M) blended 50/50. Terminal growth 3%, terminal ROIC 14%.
Three-scenario valuation:
| Bear | Base | Bull | |
|---|---|---|---|
| PV of FCFs | $10.8M | $19.2M | $32.4M |
| PV of TV (blended) | $44.5M | $101.2M | $169.3M |
| Enterprise value | $55.3M | $120.4M | $201.6M |
| Equity value | $47.3M | $112.4M | $193.6M |
| Implied share price | $4.79 | $11.24 | $19.17 |
| vs. current ($40.38) | -88% | -72% | -53% |
Probability-weighted fair value: $11.61 (25% bull, 50% base, 25% bear).
The stock is trading well above even the bull case DCF. The entire gap is non-DCF factors: scarcity premium, M&A optionality, narrative momentum. To justify $40 from base case flows, you'd need a WACC of ~4.5-5.0% (basically the risk-free rate -- absurd for a micro-cap) or revenue of $150M+ by FY2031 at 18%+ operating margins.
What the market is implying at $40: Revenue reaching $150M+ with 15%+ EBITDA margins, an acquisition at 5-6x current revenue, or a re-rating to "defense technology" multiples (20-30x EBITDA) from "defense component" multiples (12-16x). None impossible. All require things that haven't happened yet.
Where the DCF is most likely wrong: It underestimates strategic value. A strategic acquirer (Honeywell, L3Harris, Mercury Systems) would pay 5-8x revenue ($330-530M, or $34-54/share) for this franchise. The DCF also can't capture TURbO optionality, quantum sensing blue-sky, or contract non-linearity (a single $50M+ contract could reshape the 5-year trajectory).
Sensitivity
WACC vs. terminal growth (implied share price, blended):
| WACC / g | 1.5% | 2.0% | 3.0% | 4.0% | 5.0% |
|---|---|---|---|---|---|
| 8.5% | $15.80 | $17.10 | $20.95 | $27.30 | $40.55 |
| 9.5% | $13.00 | $13.95 | $16.55 | $20.60 | $28.05 |
| 10.5% | $10.85 | $11.55 | $11.24 | $16.15 | $20.75 |
| 11.5% | $9.20 | $9.70 | $10.90 | $12.80 | $15.80 |
Market price maps to ~WACC 8.5% / terminal growth 5.0%. Low discount rate + high terminal growth = best of all assumptions simultaneously.
DCF Model Health Checks
| Check | Status |
|---|---|
| TV as % of EV < 75% | FAIL (exit multiple at 82%) |
| Terminal growth < nominal GDP | PASS (3.0% < ~5%) |
| Terminal ROIC > WACC | PASS (14% > 10.5%) |
| FCF margin realistic vs peers | PASS (7.5% exit is conservative) |
| SBC dilution accounted for | PASS (0.2%/year) |
| Revenue growth decelerates | PASS (16.7% Yr 1 to 7.0% Yr 5) |
Catalysts & Risks
Catalysts
- $45M satellite contract conversion (FY2027+): Two new proliferated + traditional satellite awards announced Mar 2026. Will push backlog above $100M.
- TURbO production ramp: Miniaturized rubidium atomic clock for drone fleets/airborne radars. ~$20M/year addressable market by FY2027.
- Golden Dome missile defense program: FEIM products in missile defense chain. Bipartisan support.
- LEO satellite constellation buildout: Proliferated satellite demand at scale (higher volume, shorter life cycles = repeat business).
- CMOSS military C5ISR modernization: New defense platforms need precision timing.
- Quantum sensing commercialization: NV-diamond magnetometers expected mission-ready early 2027. Could be transformative.
- M&A takeout: At $400M market cap with irreplaceable tech, FEIM is a credible target at 5-8x revenue.
- Mercury Ion atomic clock production launch (2027).
Recent Contract Wins (Last 6 Months)
| Date | Contract | Value |
|---|---|---|
| Mar 11, 2026 | Two satellite contracts (traditional + proliferated) | ~$45M combined |
| Jan 27, 2026 | Acceleration-compensated OCXO for Link 16 radios | ~$6M follow-on |
| Jan 12, 2026 | FEI-Zyfer Assured-PNT systems | ~$6M |
| Jan 5, 2026 | Geostationary environmental satellite program | $9.2M |
| Earlier FY2026 | Precision quartz oscillators for aerospace | $11M |
| Earlier FY2026 | Military defense contract increase | $12M |
Risks
- Customer concentration (94% US government): Budget sequestration or procurement delays = direct hit. Revenue lumpiness from large contract timing is structural.
- Key-person risk: Martin Bloch (founder, ~93) has irreplaceable institutional knowledge. Limited management depth.
- Margin compression: Proliferated satellite business has "somewhat lower gross margins." Mix shifting from high-margin legacy GEO to lower-margin-per-unit (but higher-volume) proliferated programs. SG&A creeping up (Boulder facility adding ~$500K/quarter).
- Valuation risk: Trading at 55x TTM, 47x EV/EBITDA, 6x EV/Revenue with negative LTM FCF. If backlog conversion disappoints, multiple compression could be severe. Already down 34% from Jan 2026 highs.
- Liquidity risk: Cash dropped to $86K at Jan 2026 quarter-end (timing). Small float (6.88M shares), thin analyst coverage (2 analysts), volatile trading.
- Patent expiration: Key quartz oscillator and low g-sensitivity patents expired/expiring in 2026. Mitigated by broader IP portfolio and flight heritage moat.
- Supply chain: Limited space-qualified suppliers. Russia investment (Morion) fully impaired due to sanctions.
- Fixed-price contract cost overruns: Exposure on government contracts if estimates are wrong.
- Competitive threats: Microchip, Safran/Orolia, SiTime pushing into defense timing. Boeing/Northrop/Lockheed in-house capabilities.
Decision Log
2026-03-22 -- DCF completed. Three-scenario DCF produced probability-weighted fair value of $11.61 vs. $40.38 market price. The DCF is doing what it should -- discounting visible cash flows for a micro-cap defense company. The market is pricing scarcity, optionality, and M&A premium that a DCF can't capture. Fair value incorporating strategic premium is $30-45. At $40, you're paying full price for the franchise.
The honest answer: The DCF says $11-19. The market says $40. Both have rational arguments. The cash flows alone don't support the price. The market is paying for things a DCF can't model. Whether that premium is justified depends on your view of TURbO commercialization, quantum sensing potential, and M&A likelihood.
If buying at $40: You're betting on (1) TURbO + quantum reaching commercial scale, (2) backlog converting to $100M+ revenue within 3 years, and/or (3) an acquirer paying 5-8x revenue. All plausible. None guaranteed.
Status: WATCHING. The 34% pullback from $61 helped, but still not cheap enough for my framework. Would get more interested in the $25-30 range where DCF upside starts to emerge and the scarcity premium becomes free.
Research Sources
- feim-2025-01-15-fei-needham-conference-presentation
- FEIM FY2016-FY2025 earnings releases
- FEIM Q3 FY2026 earnings release
- StockAnalysis.com -- FEIM financials
- Damodaran implied ERP Jan 2026
- Treasury.gov daily yield curve
- FEIM $45M contract wins
- Craig-Hallum initiation
Topics
- defense-technology
- supply-chain-security
Briefings
- 2026-03-22 · DCF Valuation Model (FEIM) · vault